SRX sierra rutile holdings limited

Yttrium-90 for mCRC - paper from Holland

  1. 8,918 Posts.
    lightbulb Created with Sketch. 32
    An excellent paper that everyone, who can spare the time, really should read.

    In a nutshell, a few of the major views -
    A) CT scan is history. PET must be used
    B) dosage methods are discussed. The best one, that SRX suggests, is apparently seldom used in clinical practice, and not much in the recent trials.
    C) the relationship to circulating angiogenic factors, and the possible adverse impact on EHD.
    D) as a result of C, they suggest that SIRT + anti-angiogenicshould be researched


    https://dspace.library.uu.nl/handle/1874/355556
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.